XPOVIO
These highlights do not include all the information needed to use XPOVIO safely and effectively. See full prescribing information for XPOVIO. XPOVIO (selinexor) tablets, for oral useInitial U.S. Approval: 2019
f6dd2682-75a6-4863-90a8-a3197f6f78a8
HUMAN PRESCRIPTION DRUG LABEL
Jul 25, 2022
Karyopharm Therapeutics Inc.
DUNS: 061317680
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
selinexor
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
selinexor
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
selinexor
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
selinexor
Product Details
FDA regulatory identification and product classification information
